Can TTV-load help guide immunosuppression after transplant? A new meta-analysis suggests high TTV-load may signal infection risk, while low TTV-load may indicate rejection. Read more: brnw.ch/21wV4l5 #TTV #Immunosuppression #Eurofins

Did you miss us at #WTC2025? Our team had an incredible time connecting with clinicians, patients, researchers, and partners at the World Transplant Congress this year. From advancing transplant science to discussing real-world challenges, we’re grateful for the opportunity to

Managing patient coverage just got easier. We’ve partnered with our sister company, #AscendClinical, to offer a comprehensive program that fully supports coverage and billing as part of a streamlined Continuum of Care. Learn more: eurofinstransplant.com/continuum #Eurofins #PatientCare

Understanding eGFR trends is critical, not just for monitoring kidney health, but for guiding long-term transplant care. From the National Kidney Foundation, explore what the latest research says about improving eGFR: brnw.ch/21wVbsP #KidneyHealth #TransplantCare #Nephrology

We're hiring! 📣 Explore current openings and take the next step in your career with us. Be part of a dynamic environment shaping the future of healthcare and diagnostics. Check out our career opportunities here: brnw.ch/21wVcLq #Hiring #TransplantCare #JoinOurTeam

🔗 Watch more about this testing mindset here: brnw.ch/21wVfIW

We’re attending the Renal Healthcare Association Association Annual Conference to connect with others working to improve long-term outcomes in kidney transplant care. What sessions or trends are you keeping an eye on this year? Let us know down below. 💭 #RHA2025 #Eurofins #KidneyCare

Understanding silent rejection is the first step to overcoming it.💡It can be detected early with the right tools and knowledge. Equip yourself with the resources to take charge of your journey. Visit getaheadofrejection.com today. #TransplantCare #Eurofins

“Number one, we want to get these benefits but lower the risk of infection and rejection.” Dr. Thomas – 6/25/25 💬 How are you monitoring today?

Why examine biomarkers in immunosuppression? Dr. Beje Thomas explores how molecular biomarkers guide personalized Belatacept strategies for kidney & pancreas transplant patients. Watch on demand 🔗 brnw.ch/21wVqLu #Belatacept #KidneyTransplant

But how can Molecular Biomarkers help? 💬 Share your thoughts below!

Every day matters when you're waiting for life.❗️Kirsten needs kidney & liver transplants to survive for her son Axel. Read her story today and share this post to help spread the word 👉 brnw.ch/21wVz1T Transplant News #SaveALife

Post-transplant teams struggle to balance immunosuppression levels while detecting rejection early enough to act. TRAC ID changes this by combining viral surveillance + donor-derived cfDNA analysis for proactive, personalized care. Learn how: brnw.ch/21wVBiB

How are you monitoring for these risks? 💬 Share below!

Get Ahead of Rejection provides essential resources to help patients and healthcare professionals take control of outcomes and anticipate challenges before they arise. Discover proactive care 👉 getaheadofrejection.com #StayAhead #OrganRejection #BetterOutcomes

We are pleased to announce our contract award with the VA Portland Healthcare System for TRAC™. This partnership reinforces our commitment to advancing transplant care through innovative diagnostic solutions. 🤝

#RHA2025 is officially underway! Four incredible days of connecting with industry experts and discovering innovations shaping renal healthcare. Our team is ready to network, learn, and advance the future of renal care together. #RHA2025 #RenalCare #Innovation

New way to monitor kidney transplant patients: measuring Torque Teno virus (TTV) that reflects immune activity. This test shows: 🔹Higher TTV = lower rejection risk 🔹But slightly higher infection risk Could this change transplant monitoring? Read more: brnw.ch/21wVQdX

"Why is it so important to look at biomarkers, looking at immunosuppression? Because we want people not only to get transplanted, but also to have their transplants last as long as possible.” Dr. Thomas – 6/25/25 💬 What innovation are you using to increase graft survival?

Looking for a more integrated approach to lab testing? We've partnered with our sister company, #AscendClinical to deliver our unique Continuum of Care - combining #TruGraf, #Trac, and standard labs in one seamless process. Learn more: eurofinstransplant.com/continuum #TransplantCare